Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity.

BACKGROUND Community-acquired pneumonia frequently constitutes a nonsevere infection manageable at home. However, for these low-risk episodes, the epidemiological features have not been carefully analyzed. OBJECTIVES To determine the cause of nonsevere community-acquired pneumonia and to investigate if a correlation exists between cause and severity or comorbidity. METHODS During a 3-year period, all patients with nonsevere community-acquired pneumonia, according to the Pneumonia Patient Outcome Research Team prognostic classification (patients in groups 1-3), were included in the study. Causes were investigated through the following procedures: cultures of blood, sputum, and pleural fluid; serologic tests; and polymerase chain reaction methods to detect Streptococcus pneumoniae DNA in whole blood or Mycoplasma pneumoniae and Chlamydia pneumoniae DNA in throat swab specimens. RESULTS Of 317 initially included patients, 247 were eligible for the study. A microbial diagnosis was obtained in 162 patients (66%), and the main pathogens detected were S pneumoniae (69 patients [28%]), M pneumoniae (40 patients [16%]), and C pneumoniae (28 patients [11%]). For the 58 patients in prognostic group 1, M pneumoniae was the most prevalent cause, and atypical microorganisms constituted 40 (69%) of the isolated agents. In contrast, for patients in prognostic groups 2 and 3, S pneumoniae was the leading agent, and a significant reduction of M pneumoniae cases and a greater presence of other more uncommon pathogens were observed. The existence of comorbid conditions was not a determining factor for particular causes. CONCLUSIONS Among low-risk patients with community-acquired pneumonia, there was a certain correlation between severity and cause. In contrast, the existence of a comorbidity did not have a predictive causative value.

[1]  J. Dorca,et al.  Diagnóstico y tratamiento de la neumonía adquirida en la comunidad , 1997 .

[2]  G. Boulnois,et al.  Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae , 1987, Infection and immunity.

[3]  I. Bolíbar,et al.  Epidemiology of community-acquired pneumonia in adults: a population-based study. , 2000, The European respiratory journal.

[4]  F. Ognibene,et al.  The Laboratory Evaluation of Opportunistic Pulmonary Infections , 1996, Annals of Internal Medicine.

[5]  J. Bonnet,et al.  Detection of Mycoplasma pneumoniae by using the polymerase chain reaction , 1989 .

[6]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[7]  J. Macfarlane An overview of community acquired pneumonia with lessons learned from the British Thoracic Society Study. , 1994, Seminars in respiratory infections.

[8]  J. Bartlett,et al.  GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management , 1998 .

[9]  O. Ruuskanen,et al.  Pneumolysin PCR-Based Diagnosis of Invasive Pneumococcal Infection in Children , 1999, Journal of Clinical Microbiology.

[10]  J. Ramirez,et al.  Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. , 1996, Diagnostic microbiology and infectious disease.

[11]  M. Lorente,et al.  Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study , 2000, Thorax.

[12]  M. Fine,et al.  Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. , 1999, Archives of internal medicine.

[13]  B. Afessa,et al.  Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. , 2000, Chest.

[14]  S. Skerrett Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. , 1997, Seminars in respiratory infections.

[15]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[16]  S. Ewig,et al.  Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. , 1999, The European respiratory journal.

[17]  J. Heesemann,et al.  Molecular Approaches to Diagnosis of Pulmonary Diseases Due toMycoplasma pneumoniae , 1998, Journal of Clinical Microbiology.

[18]  Y. Chen,et al.  A prognostic rule for elderly patients admitted with community-acquired pneumonia. , 1999, The American journal of medicine.

[19]  M. Leinonen,et al.  Detection of pneumococcus from whole blood, buffy coat and serum samples by PCR during bacteremia in mice , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[21]  D. Singer,et al.  Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. , 1998, Archives of internal medicine.

[22]  T. Quinn,et al.  Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  W. Clyde,et al.  Clinical overview of typical Mycoplasma pneumoniae infections. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  T. Kawayama,et al.  [Detection of Chlamydia pneumoniae by polymerase chain reaction]. , 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[25]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[26]  M. García,et al.  Transthoracic needle aspiration in the study of pulmonary infections in patients with HIV. , 1994, Chest.

[27]  M. Salavert,et al.  Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. , 1999, American journal of respiratory and critical care medicine.